NCT03160443

Brief Summary

Eating disorders are multifactorial disorders currently conceptualized in a biopsychosocial model, but pathophysiology remains relatively unknown, and robust etiological models to guide treatment are therefore lacking. Different endophenotypes and neurocognitive vulnerability factors have been found in eating disorders including decision making abnormalities. The investigators hypothesize that decision making abnormalities are associated with a lower level of functioning and quality of life which could lead to social and interpersonal difficulties. The investigators also hypothesize that these anomalies are associated with a particular clinical profile (more restrictive profile, more hyperactivity, less insight on the disease and desire for care ...).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
340

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2017

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 3, 2017

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

May 11, 2017

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 19, 2017

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 30, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 30, 2022

Completed
Last Updated

December 21, 2021

Status Verified

December 1, 2021

Enrollment Period

5.2 years

First QC Date

May 11, 2017

Last Update Submit

December 20, 2021

Conditions

Keywords

Anorexia nervosaBulimiaBinge eating disordersNeuropsychologyNeurocognitionDaily functioning

Outcome Measures

Primary Outcomes (1)

  • Level of functional impairment assessed by the Work and Social Adjustment Scale (WSAS)

    We aim to investigate the link between decision-making and daily functioning of patients with eating disorder.

    Baseline

Secondary Outcomes (9)

  • Quality of life assessed by the Eating disorder quality of life (EDQOL) scale.

    Baseline

  • Level of functional impairment assessed by the clinician with the Functional Assessment Staging Test (FAST) scale

    Baseline

  • Quality of life assessed by the Eating disorder quality of life (EDQOL) scale.

    Baseline

  • Level of functional impairment assessed by the clinician with the FAST scale

    Baseline

  • Score to decision making test (Iowa gambling task)

    At 12 months if patient is included in the ancillary study

  • +4 more secondary outcomes

Study Arms (1)

Participants

OTHER

All participants performed the same evaluation: clinical and neuropsychological assessment. All of them are patients with an eating disorder.

Behavioral: Ambulatory cares in a day-hospital (University Hospital of Montpellier) specialized in the evaluation of eating disorders

Interventions

All patients assessed in the day-hospital will performed the same evaluation : * Blood sampling * Calorimetry * Osteodensitometry * Psychiatric assessment * Endocrinologic assessment * Dietetic assessment * Neuropsychological assessment * Self-questionnaires With the patient agreement, a biological collection will be constituted. The objective is the subsequent study of biological factors involved in eating disorders (in particular genetic factors)

Participants

Eligibility Criteria

Age15 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patient with an eating disorder according to Diagnostic and Statistical Manuel of Mental disorders-V (DSM-V) criteria
  • Patient aged from 15 to 65 years
  • Patient who performs the day-hospital evaluation
  • Patient affiliated to a French social security system
  • Patient able to understand the nature, the aim and the methodology of the study
  • For minor one of the legal guardians gave his consent

You may not qualify if:

  • Patient in an unstable somatic state (eg severe metabolic disorder making impossible or unreliable neuropsychological assessments)
  • Patient's refusal to participate
  • Patient on protective measures (guardianship or trusteeship)
  • Pregnant or nursing women. A dosage of beta human chorionic gonadotropin (βHCG) will be performed to ensure the absence of pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Lapeyronie

Montpellier, 34295, France

Location

MeSH Terms

Conditions

Feeding and Eating DisordersAnorexia NervosaBulimiaBinge-Eating Disorder

Condition Hierarchy (Ancestors)

Signs and Symptoms, DigestiveSigns and SymptomsPathological Conditions, Signs and SymptomsMental DisordersHyperphagia

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 11, 2017

First Posted

May 19, 2017

Study Start

May 3, 2017

Primary Completion

July 30, 2022

Study Completion

July 30, 2022

Last Updated

December 21, 2021

Record last verified: 2021-12

Data Sharing

IPD Sharing
Will not share

Locations